Bobby Brown, DO
Family Medicine · Prattville, ALNPI 1336117183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 36.5% of the total. Reporting peaked in 2021 at $214 and has fallen 76.1% since, to $51 in 2025. That places this record below the midpoint for family medicine clinicians in AL, where the typical reported total is $638.
Across 37 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$217
- Portola Pharmaceuticals, LLC$123
- Pfizer$87
- Medtronic$36
- E.r. Squibb & Sons, L.L.C.$24
- Bioxcel Therapeutics, Inc.$23
- plus $84 from 6 others
Across 93 payments — averaging $6919.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$438K
- Boehringer Ingelheim International GmbH$110K
- Boehringer Ingelheim Pharma GmbH & Co.kg$66K
- Ortho-clinical Diagnostics, Inc.$30K
What the payments were for
- Speaking & faculty fees$20%
- Food & beverage$593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $217 |
| Portola Pharmaceuticals, LLC | 10 | $123 |
| Pfizer | 5 | $87 |
| Medtronic | 1 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Bioxcel Therapeutics, Inc. | 1 | $23 |
| Penumbra, Inc. | 1 | $22 |
| AstraZeneca | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
| Urogen Pharma, Inc. | 1 | $15 |
| Purdue Pharma L.p. | 1 | $14 |
| Medline Industries LP | 1 | $2 |
How this compares
$594 in reported general payments places this provider in the 45th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $188 |
| Methylprednisolone | 13 | $118 |
| Cyclobenzaprine Hcl | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Prattville
- Lashelle BarmoreBirmingham$486K
- Regina BenjaminBayou la Batre$222K
- Jonathan ParkerMuscle Shoals$214K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Kelly HunterTuscaloosa$84K
- Daniel EnglertHuntsville$82K
- Joel LaughlinMobile$75K
- Ashleigh Butts-WilkersonMobile$54K
- Philip WilsonDothan$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.